MedPath

Associations of Vitamin D Deficiency and Vitamin D Receptor Polymorphisms With the Risk of Primary Open-angle Glaucoma

Completed
Conditions
Vitamin D Deficiency
Primary Open- Angle Glaucoma
Interventions
Other: Vitamin D receptor polymorphic analysis
Other: Serum levels of 1a, 25-Dihydroxyvitamin D3
Registration Number
NCT02539745
Lead Sponsor
Lv Yingjuan
Brief Summary

This study investigated whether vitamin D receptor gene polymorphism is altered in primary open-angle glaucoma subjects carrying the risk allele and vitamin D deficiency is an important factor in the development of glaucoma. Primary open-angle glaucoma patients and age-matched people in the Han population were enrolled. Serum levels of 1a, 25-Dihydroxyvitamin D3 were measured by enzyme-linked immunoabsorbent assay. Vitamin D receptor polymorphic analysis was studied by real-time polymerase-chain reaction high resolution melting analysis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • intraocular pressure greater than 22 mmHg with two or more medications
  • wide anterior chamber angle
  • glaucomatous optic neuropathy (Glaucomatous optic nerve damage was defined as cup-to-disc ratio higher than 0.7 or focal loss of the nerve fiber layer (notch) associated with a consistent glaucomatous visual field defect)
  • visual field loss consistent with optic nerve damage and visual fields were performed by using standard automated perimetry
Exclusion Criteria
  • the presence of any secondary glaucoma including exfoliation syndrome or a history of ocular trauma
  • high myopia
  • macular degeneration
  • other ocular diseases
  • a known history of systemic diseases and administration of vitamin D3 or other analog

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
primary open-angle glaucoma patientsVitamin D receptor polymorphic analysisSerum levels of 1a, 25-Dihydroxyvitamin D3 were measured by enzyme-linked immunoabsorbent assay and vitamin D receptor polymorphic analysis was studied by real-time polymerase-chain reaction high resolution melting analysis in primary open-angle glaucoma patients.
randomly age-matched peopleSerum levels of 1a, 25-Dihydroxyvitamin D3Serum levels of 1a, 25-Dihydroxyvitamin D3 were measured by enzyme-linked immunoabsorbent assay and vitamin D receptor polymorphic analysis was studied by real-time polymerase-chain reaction high resolution melting analysis in randomly age-matched people.
primary open-angle glaucoma patientsSerum levels of 1a, 25-Dihydroxyvitamin D3Serum levels of 1a, 25-Dihydroxyvitamin D3 were measured by enzyme-linked immunoabsorbent assay and vitamin D receptor polymorphic analysis was studied by real-time polymerase-chain reaction high resolution melting analysis in primary open-angle glaucoma patients.
randomly age-matched peopleVitamin D receptor polymorphic analysisSerum levels of 1a, 25-Dihydroxyvitamin D3 were measured by enzyme-linked immunoabsorbent assay and vitamin D receptor polymorphic analysis was studied by real-time polymerase-chain reaction high resolution melting analysis in randomly age-matched people.
Primary Outcome Measures
NameTimeMethod
Serum levels of 1a, 25-Dihydroxyvitamin D31 day visit
Secondary Outcome Measures
NameTimeMethod
gene polymorphisms of vitamin D receptor1 day visit

Trial Locations

Locations (1)

Tianjin Medical University Eye Hospital

🇨🇳

Tianjin, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath